Aloka to buy Ecotron Holding

Article

Ultrasound vendor Aloka of Tokyo last month agreed to purchase its European distributor, Ecotron Holding of Zug, Switzerland. The deal, valued at about $3.5 million and subject to Ecotron shareholder approval, will create a sales, marketing, and customer

Ultrasound vendor Aloka of Tokyo last month agreed to purchase its European distributor, Ecotron Holding of Zug, Switzerland. The deal, valued at about $3.5 million and subject to Ecotron shareholder approval, will create a sales, marketing, and customer support operation called Aloka Holding (Europe). The firms hoped to complete the merger last month.

Aloka's purchase of Ecotron covers Ecotron's sales and service assets, including divisions in France, Italy, and Spain. All 70 Ecotron employees will be absorbed into the new firm, and its distributor network across Eastern Europe will be restructured. Roberto Bucciarelli, president and CEO of Ecotron, will become president of Aloka Holding (Europe). With the acquisition, Aloka will increase its access to the European market, according to Masayuki Kai, Aloka president. Aloka posts worldwide revenues of about $350 million.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.